Sa-Hee Park

Integrative genomic analysis reveals cancer-associated mutations at diagnosis of CML in patients with high-risk disease

Susan Branford, Paul Wang, David T Yeung et al. · Blood · 2018 · 209 citations · Full text

Medicine, Genetics, Molecular Genetics +12

Early BCR-ABL1 kinetics are predictive of subsequent achievement of treatment-free remission in chronic myeloid leukemia

Naranie Shanmuganathan, Ilaria S. Pagani, David M. Ross et al. · Blood · 2020 · 86 citations

Medicine, Hematology, Oncology +7

Previous best responses can be re-achieved by resumption after imatinib discontinuation in patients with chronic myeloid leukemia: implication for intermittent imatinib therapy

Hyun‐Gyung Goh, Yoo‐Jin Kim, Dong‐Wook Kim et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2009 · 58 citations

Medicine, Hematology, Oncology +16

Analysis of Bcr‐Abl kinase domain mutations in Korean chronic myeloid leukaemia patients: poor clinical outcome of P‐loop and T315I mutation is disease phase dependent

Soo‐Hyun Kim, Dong‐Ho Kim, Dong‐Ho Kim et al. · Hematological Oncology · 2009 · 55 citations

Medicine, Genetics, Hematology +9

Comprehensive therapeutic outcomes of frontline imatinib mesylate in newly diagnosed chronic phase chronic myeloid leukemia patients in Korea: feasibility assessment of current ELN recommendation

Dongho Kim, Hyun Gyung Goh, Soo‐Hyun Kim et al. · International Journal of Hematology · 2012 · 27 citations

Medicine, Pharmacology, Pharmacotherapy +6